Please login to the form below

Not currently logged in

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Novartis launches YouTube cancer talk show

Each Voice Counts forms part of firm’s existing advanced breast cancer initiative
Novartis YouTube advanced breast cancer talk show

Novartis is using YouTube to broadcast a new talk show about advanced breast cancer as part of its ongoing disease awareness efforts in the area.

The first episode of its Each Voice Counts talk show series features four women sharing their stories of life with the condition.

Novartis' key product in the area is Afinitor (everolimus), which gained European approval for advanced breast cancer in July, just days after US regulators passed it for the same indication.

The Each Voice Counts talk show follows the re-launch last week of Novartis' global website.

The website is a collaboration between Novartis and Inspire, which builds and manages online support communities for patients and carers.

Advanced Breast Cancer Community offers a 'clearing house' of tailored information, covering topics such as creating a personal care plan and metastasis and recurrence.

Novartis' use of YouTube for videos in a talk show format, though unusual, is not unique, and has echoes of the Johnson & Johnson's employee video series ennTV, which debuted in April and the New Way RA talk show it began in 2009.

9th October 2012

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
GEM Marketing Ltd

GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...